Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03160742 · ClinicalTrials.gov registry record
Pilot Study of a Non-Invasive Central Venous Pressure Monitoring System in Children
A clinical trial, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- 1
- Enrollment target
NCT03160742 is a clinical trial that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 1 participants.
The verdict
NCT03160742 was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The goal of this research study is to determine the feasibility and accuracy of Mespere Life Science non-invasive central venous pressure monitoring system (Mespere VENUS 2000CVP system) in children with congenital heart disease (CHD).
Interventions
- DEVICE Mespere VENUS 200CVP system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-04-25 |
| Est. Completion | 2018-09-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03160742
The ClinicalTrials.gov registry entry for NCT03160742 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mespere VENUS 200CVP system is the first listed.
NCT03160742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03160742 about?
NCT03160742 is a clinical study titled "Pilot Study of a Non-Invasive Central Venous Pressure Monitoring System in Children". The goal of this research study is to determine the feasibility and accuracy of Mespere Life Science non-invasive central venous pressure monitoring system (Mespere VENUS 2000CVP system) in children with congenital heart disease (CHD).
What is the current status of trial NCT03160742?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2018-04-25. Estimated completion is 2018-09-14.
What interventions are being tested in trial NCT03160742?
The interventions under investigation include: Mespere VENUS 200CVP system (DEVICE).
Who is sponsoring clinical trial NCT03160742?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.